US Stock MarketDetailed Quotes

ALXO ALX Oncology

Watchlist

14.210
-0.450-3.07%

Close May 17 16:00 ET

14.000
-0.210-1.48%

Post 16:03 ET

740.34MMarket Cap-3830P/E (TTM)

ALX Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-36.34%-37.92M

-46.11%-130.36M

-91.98%-39.68M

-0.89%-31.16M

-86.56%-31.71M

-34.55%-27.82M

-31.02%-89.22M

-18.18%-20.67M

-24.25%-30.88M

17.57%-17M

Net income from continuing operations

-17.88%-35.58M

-30.23%-160.81M

-48.07%-45.47M

-44.37%-50.99M

-3.76%-34.16M

-23.03%-30.18M

-47.95%-123.48M

-7.99%-30.71M

-43.78%-35.32M

-102.29%-32.92M

Operating gains losses

--10K

----

Depreciation and amortization

0.47%214K

144.44%836K

97.14%207K

120.00%209K

146.43%207K

267.24%213K

570.59%342K

208.82%105K

1,483.33%95K

1,300.00%84K

Other non cash items

40.16%513K

30.31%1.52M

18.18%416K

23.18%372K

87.76%368K

15.09%366K

-78.47%1.17M

-92.91%352K

17.97%302K

34.25%196K

Change In working capital

-148.20%-8.56M

-15.77%8.3M

-91.67%331K

881.42%14.13M

-127.67%-2.71M

-62.26%-3.45M

344.60%9.85M

1,393.61%3.97M

61.88%-1.81M

245.61%9.81M

-Change in prepaid assets

-2,749.41%-4.5M

12.53%-1.29M

165.52%3.02M

2.90%-2.35M

-254.45%-2.13M

110.78%170K

11.19%-1.48M

199.21%1.14M

-59.96%-2.42M

1,870.51%1.38M

-Change in payables and accrued expense

22.39%-3.57M

-8.47%10.58M

-73.11%527K

1,990.51%17.18M

-129.08%-2.53M

-7,183.08%-4.6M

44.14%11.55M

16.95%1.96M

159.18%822K

4,388.67%8.71M

-Change in other current assets

-87.34%149K

82.13%1.37M

-380.14%-2.85M

1,449.02%790K

224,900.00%2.25M

471.29%1.18M

107.75%750K

4.74%1.02M

103.16%51K

99.99%-1K

-Change in other current liabilities

-229.84%-630K

-140.84%-2.35M

-159.57%-366K

-467.80%-1.5M

-7.61%-297K

35.47%-191K

-39.97%-977K

94.89%-141K

-15.79%-264K

-113.81%-276K

Cash from discontinued investing activities

Operating cash flow

-36.34%-37.92M

-46.11%-130.36M

-91.98%-39.68M

-0.89%-31.16M

-86.56%-31.71M

-34.55%-27.82M

-31.02%-89.22M

-18.18%-20.67M

-24.25%-30.88M

17.57%-17M

Investing cash flow

Cash flow from continuing investing activities

-37.41%26.47M

118.97%44.66M

-252.31%-16.67M

-6.43%12.82M

108.16%6.21M

123.00%42.3M

-4,681.96%-235.42M

342.19%10.94M

3,540.95%13.7M

-76.13M

Net PPE purchase and sale

78.55%-148K

10.72%-1.27M

61.95%-148K

778.65%1.3M

-576.65%-1.74M

-17.15%-690K

-114.26%-1.43M

-49.04%-389K

51.76%-192K

---257K

Net intangibles purchase and sale

----

--0

----

--0

----

Net investment purchase and sale

-38.07%26.62M

119.63%45.93M

-245.78%-16.52M

-17.10%11.51M

110.48%7.95M

123.45%42.99M

---233.99M

--11.33M

--13.89M

---75.88M

Cash from discontinued investing activities

Investing cash flow

-37.41%26.47M

118.97%44.66M

-252.31%-16.67M

-6.43%12.82M

108.16%6.21M

123.00%42.3M

-4,681.96%-235.42M

342.19%10.94M

3,540.95%13.7M

---76.13M

Financing cash flow

Cash flow from continuing financing activities

2,984.11%3.09M

501.33%59.29M

523.19%59.17M

18.38%-111K

-18.72%343K

-233.75%-107K

298.87%9.86M

1,711.83%9.49M

-130.98%-136K

-42.27%422K

Net issuance payments of debt

-63.55%-175K

-104.04%-388K

-100.64%-63K

21.28%-111K

-205.71%-107K

-1.90%-107K

3,520.64%9.61M

9,612.50%9.89M

-35.58%-141K

52.05%-35K

Net common stock issuance

--3.02M

--58.89M

----

--0

----

Proceeds from stock option exercised by employees

--237K

-12.29%792K

33.59%342K

--0

-1.53%450K

--0

-67.20%903K

-59.24%256K

-99.08%5K

-43.16%457K

Net other financing activities

----

---655K

----

Cash from discontinued financing activities

Financing cash flow

2,984.11%3.09M

501.33%59.29M

523.19%59.17M

18.38%-111K

-18.72%343K

-233.75%-107K

298.87%9.86M

1,711.83%9.49M

-130.98%-136K

-42.27%422K

Net cash flow

Beginning cash position

-54.03%22.47M

-86.56%48.89M

-60.00%19.65M

-42.65%38.11M

-60.25%63.26M

-86.56%48.89M

-16.25%363.67M

-87.25%49.12M

-83.79%66.44M

-62.98%159.15M

Current changes in cash

-158.20%-8.37M

91.61%-26.42M

1,316.38%2.82M

-6.53%-18.46M

72.87%-25.16M

107.03%14.37M

-346.17%-314.78M

98.92%-232K

30.19%-17.32M

-366.08%-92.71M

End cash Position

-77.70%14.11M

-54.03%22.47M

-60.00%19.65M

-42.65%38.11M

-60.25%63.26M

-86.56%48.89M

-87.25%49.12M

-83.79%66.44M

Free cash flow

-33.56%-38.07M

-45.22%-131.64M

-89.13%-39.83M

3.92%-29.86M

-93.86%-33.45M

-34.06%-28.51M

-24.14%-90.65M

4.31%-21.06M

-23.05%-31.08M

16.33%-17.26M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-36.34%-37.92M	-46.11%-130.36M	-91.98%-39.68M	-0.89%-31.16M	-86.56%-31.71M	-34.55%-27.82M	-31.02%-89.22M	-18.18%-20.67M	-24.25%-30.88M	17.57%-17M
Net income from continuing operations	-17.88%-35.58M	-30.23%-160.81M	-48.07%-45.47M	-44.37%-50.99M	-3.76%-34.16M	-23.03%-30.18M	-47.95%-123.48M	-7.99%-30.71M	-43.78%-35.32M	-102.29%-32.92M
Operating gains losses	--10K	----	----	----	----	----	----	----	----	----
Depreciation and amortization	0.47%214K	144.44%836K	97.14%207K	120.00%209K	146.43%207K	267.24%213K	570.59%342K	208.82%105K	1,483.33%95K	1,300.00%84K
Other non cash items	40.16%513K	30.31%1.52M	18.18%416K	23.18%372K	87.76%368K	15.09%366K	-78.47%1.17M	-92.91%352K	17.97%302K	34.25%196K
Change In working capital	-148.20%-8.56M	-15.77%8.3M	-91.67%331K	881.42%14.13M	-127.67%-2.71M	-62.26%-3.45M	344.60%9.85M	1,393.61%3.97M	61.88%-1.81M	245.61%9.81M
-Change in prepaid assets	-2,749.41%-4.5M	12.53%-1.29M	165.52%3.02M	2.90%-2.35M	-254.45%-2.13M	110.78%170K	11.19%-1.48M	199.21%1.14M	-59.96%-2.42M	1,870.51%1.38M
-Change in payables and accrued expense	22.39%-3.57M	-8.47%10.58M	-73.11%527K	1,990.51%17.18M	-129.08%-2.53M	-7,183.08%-4.6M	44.14%11.55M	16.95%1.96M	159.18%822K	4,388.67%8.71M
-Change in other current assets	-87.34%149K	82.13%1.37M	-380.14%-2.85M	1,449.02%790K	224,900.00%2.25M	471.29%1.18M	107.75%750K	4.74%1.02M	103.16%51K	99.99%-1K
-Change in other current liabilities	-229.84%-630K	-140.84%-2.35M	-159.57%-366K	-467.80%-1.5M	-7.61%-297K	35.47%-191K	-39.97%-977K	94.89%-141K	-15.79%-264K	-113.81%-276K
Cash from discontinued investing activities
Operating cash flow	-36.34%-37.92M	-46.11%-130.36M	-91.98%-39.68M	-0.89%-31.16M	-86.56%-31.71M	-34.55%-27.82M	-31.02%-89.22M	-18.18%-20.67M	-24.25%-30.88M	17.57%-17M
Investing cash flow
Cash flow from continuing investing activities	-37.41%26.47M	118.97%44.66M	-252.31%-16.67M	-6.43%12.82M	108.16%6.21M	123.00%42.3M	-4,681.96%-235.42M	342.19%10.94M	3,540.95%13.7M	-76.13M
Net PPE purchase and sale	78.55%-148K	10.72%-1.27M	61.95%-148K	778.65%1.3M	-576.65%-1.74M	-17.15%-690K	-114.26%-1.43M	-49.04%-389K	51.76%-192K	---257K
Net intangibles purchase and sale	----	--0	----	----	----	----	--0	----	----	----
Net investment purchase and sale	-38.07%26.62M	119.63%45.93M	-245.78%-16.52M	-17.10%11.51M	110.48%7.95M	123.45%42.99M	---233.99M	--11.33M	--13.89M	---75.88M
Cash from discontinued investing activities
Investing cash flow	-37.41%26.47M	118.97%44.66M	-252.31%-16.67M	-6.43%12.82M	108.16%6.21M	123.00%42.3M	-4,681.96%-235.42M	342.19%10.94M	3,540.95%13.7M	---76.13M
Financing cash flow
Cash flow from continuing financing activities	2,984.11%3.09M	501.33%59.29M	523.19%59.17M	18.38%-111K	-18.72%343K	-233.75%-107K	298.87%9.86M	1,711.83%9.49M	-130.98%-136K	-42.27%422K
Net issuance payments of debt	-63.55%-175K	-104.04%-388K	-100.64%-63K	21.28%-111K	-205.71%-107K	-1.90%-107K	3,520.64%9.61M	9,612.50%9.89M	-35.58%-141K	52.05%-35K
Net common stock issuance	--3.02M	--58.89M	----	----	----	--0	--0	----	----	----
Proceeds from stock option exercised by employees	--237K	-12.29%792K	33.59%342K	--0	-1.53%450K	--0	-67.20%903K	-59.24%256K	-99.08%5K	-43.16%457K
Net other financing activities	----	----	----	----	----	----	---655K	----	----	----
Cash from discontinued financing activities
Financing cash flow	2,984.11%3.09M	501.33%59.29M	523.19%59.17M	18.38%-111K	-18.72%343K	-233.75%-107K	298.87%9.86M	1,711.83%9.49M	-130.98%-136K	-42.27%422K
Net cash flow
Beginning cash position	-54.03%22.47M	-86.56%48.89M	-60.00%19.65M	-42.65%38.11M	-60.25%63.26M	-86.56%48.89M	-16.25%363.67M	-87.25%49.12M	-83.79%66.44M	-62.98%159.15M
Current changes in cash	-158.20%-8.37M	91.61%-26.42M	1,316.38%2.82M	-6.53%-18.46M	72.87%-25.16M	107.03%14.37M	-346.17%-314.78M	98.92%-232K	30.19%-17.32M	-366.08%-92.71M
End cash Position	-77.70%14.11M	-54.03%22.47M	-54.03%22.47M	-60.00%19.65M	-42.65%38.11M	-60.25%63.26M	-86.56%48.89M	-86.56%48.89M	-87.25%49.12M	-83.79%66.44M
Free cash flow	-33.56%-38.07M	-45.22%-131.64M	-89.13%-39.83M	3.92%-29.86M	-93.86%-33.45M	-34.06%-28.51M	-24.14%-90.65M	4.31%-21.06M	-23.05%-31.08M	16.33%-17.26M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall